Agoracom Blog Home

Posts Tagged ‘Aphria Inc’

$HOLL Announces Closing of $7.9M Private Placement of Special Warrants, Including Full Exercise of Agents’ Option $CRON $GTBIF $INDS $META.ca $FAF.ca $WEED.ca

Posted by Jesse Champagne at 3:39 PM on Tuesday, March 2nd, 2021
Hollister Biosciences Inc. | CSE - Canadian Securities Exchange
  • The Company has now closed the brokered private placement of 21,635,094  Special Warrants and raised gross proceeds of $7,896,809.31

VANCOUVER, BC – March 2, 2021 – Hollister Biosciences Inc. (CSE:HOLL, OTC:HSTRF, FRANKFURT:HOB) (“Hollister” or the “Company”) is pleased to announce, further to its news releases of January 21, 2021, and January 20, 2021, that the Company has now closed the brokered private placement of 21,635,094  Special  Warrants of the  Company  (the  “Special  Warrants”)  at a  price of  $0.365  per  Special  Warrant and raised gross proceeds of $7,896,809.31 (the “Offering”), including 3,825,094 Special Warrants sold pursuant to the exercise in full of the agents’ option granted to the Agents (as defined herein).

Eight Capital acted as sole bookrunner and lead agent on behalf of a syndicate of agents including Haywood Securities Inc. and Paradigm Capital Inc. (together with Eight Capital, the “Agents”) under the Offering.

Each Special Warrant will be automatically exercisable into units of the Company (the “Units”), as described below. Each Unit consists of one common share of the Company (a “Share”) and one-half of one common share purchase warrant (each full warrant, a “Warrant”). Each Warrant will entitle the holder thereof to acquire one Share at a price of $0.50 per Share on or before January 2, 2025, being 46 months following the date of closing of the Offering (the “Closing Date”).

Each Special Warrant will be automatically exercisable, for no additional consideration, into Units on the date (the “Automatic Exercise Date”) that is the earlier of: (i) the date that is three business days following the date on which the Company either (A) obtains a receipt from the applicable securities regulatory authorities (the “Securities Commissions”) for a (final) short form prospectus qualifying distribution of the Units underlying the Special Warrants (the “Qualifying Prospectus”); or (B) files a supplement to a (final) short form base shelf prospectus qualifying the distribution of the Units underlying the Special Warrants (the “Qualifying Supplement”), and (ii) July 3, 2021, being the date that is four months and one day after the closing of the Offering.

Notwithstanding the foregoing, in the event the Company has not received a receipt from the Securities Commissions for the Qualifying Prospectus or filed a Qualifying Supplement on or before March 12, 2021, each holder of Special Warrants shall thereafter be entitled to acquire an additional one-half of one (0.5) Warrant for each Unit to be issued to such holder upon the automatic exercise of the Special Warrants, such that each Unit shall be comprised of one Share and one whole Warrant (collectively, the “Penalty Warrants”), without further payment or action on the part of the holder.

In connection with the Offering, the Company paid the Agents $651,084.20 in commissions and advisory fees and issued 1,441,580 special broker warrants (the “Special Broker Warrants”) to the Agents. Each Special Broker Warrant is automatically exercisable into one broker warrant (a “Broker Warrant”) for no additional payment on the Automatic Exercise Date. Each Broker Warrant will be exercisable into one Unit, subject to adjustment, at $0.365 per Unit for a period of 24 months from the closing of the Offering. Each Unit is comprised of one Share and one-half of one Warrant.

All securities issued in connection with the Offering are subject to a statutory hold period of four months plus a day in accordance with applicable securities legislation ending on July 3, 2021. The net proceeds received from the Offering will be used for working capital and general corporate purposes.

Read more HERE.

TransCanna’s $TCAN.ca Lyfted Farms Set to Increase Cultivation by 300% $VFF.ca $ACB.ca $GTII.ca $TEQ.ca

Posted by Jesse Champagne at 9:51 AM on Tuesday, March 2nd, 2021
tcan-square

  • Company anticipates escalation in cultivation to have direct effect on revenue growth
  • Strategic location of the Company’s new facility takes full advantage of California’s lowest industrial electrical costs
  • “Our new facility gives us a massive competitive cost advantage that will increase our margins and empower us to offer consumers the best products at the most competitive prices,” said Bob Blink

Vancouver, British Columbia–(Newsfile Corp. – March 2, 2021) – TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (OTC: TCNAF) (“TransCanna” or the “Company”) has increased its cultivation capacity by 300%, enabling it to effectively triple production of its most profitable and in-demand product: exotic indoor flower. With this increased cultivation capacity, Lyfted Farms – hailed in the industry for its premium genetics and seasoned team of master cultivators – can now meet consumer-driven demand in Northern California while expanding into the sizable Southern California home containing over 23,000,000 residents.

“We literally cannot keep up with demand as the vast majority of shipments are selling out within days of landing on retail shelves,” said Alan Applonie, General Manager for TransCanna subsidiary, Lyfted Farms. “We have been waiting for the right time to enter the Southern California market but needed this increase in cultivation capacity to effectively build and preserve our reputation for unwavering quality and reliability with our retailers and consumers,” said Mr. Applonie.

In addition to increasing output, the strategic location of the Company’s new Daly facility in Modesto, California, takes full advantage of California’s lowest industrial electrical costs per kilowatt-hour.

“Electricity is the largest direct cost for indoor cultivation so the location of our new facility gives us a massive competitive cost advantage that will increase our margins and empower us to offer consumers the best products at the most competitive prices,” said Bob Blink, CEO of TransCanna.

The additional cultivation rooms coming online within the Daly facility also unlock Lyfted Farms’ ability to leverage its multi-decade relationships within the industry. The expansion in cultivation capacity opens the door for collaboration with other dominant California cannabis lifestyle brands. Ensuing co-branding efforts (soon to be revealed) will be powerful and will impact all meaningful cannabis market segments within the state.

The new developments represent significant strides in TransCanna’s mission to establish itself as California’s leading cannabis conglomerate.

Read more: https://agoracom.com/ir/TranscannaHoldings/forums/discussion/topics/756376-transcanna-s-lyfted-farms-set-to-increase-cultivation-by-300/messages/2306057#message

California Grants #Cannabis Cultivation License to TransCanna $TCAN.ca $VFF.ca $ACB.ca $GTII.ca $TEQ.ca

Posted by AGORACOM-JC at 3:24 PM on Saturday, February 20th, 2021
tcan-square

Game-changing achievement for the budding cannabis enterprise

  • Received a highly coveted cultivation license from the State of California that will accelerate the Company’s cultivation capacity almost immediately
  • license represents a major milestone achievement in its endeavors to be California’s leading fully integrated cannabis cultivator, processor, manufacturer, wholesaler and distributor
  • “Obtaining this license is a significant turning point for TransCanna and opens up the door to the explosive growth we’ve been positioning ourselves for,” said Bob Blink

Vancouver, British Columbia–(February 20, 2021) –  TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) is pleased to announce that it has received a highly coveted cultivation license from the State of California that will accelerate the Company’s cultivation capacity almost immediately.

The State of California has granted a cultivation license to Lyfted Farms – a TransCanna wholly owned subsidiary – for its flagship Daly facility in Modesto, California. Bob Blink, TransCanna CEO states “Such cultivation licenses in the region are notoriously difficult to obtain. Current applications are back-logged and not even being considered for processing by the county until the end of 2021.”

For TransCanna, the license represents a major milestone achievement in its endeavors to be California’s leading fully integrated cannabis cultivator, processor, manufacturer, wholesaler and distributor.

“Obtaining this license is a significant turning point for TransCanna and opens up the door to the explosive growth we’ve been positioning ourselves for,” said Bob Blink. “Demand has been consistently outstripping supply for our exotic indoor cannabis strains, and now with this new massive facility receiving approval for cultivation, we can finally meet that demand and continue to scale. This will make us one of the largest licensed facilities of its kind in the State of California.”

In addition to cultivation, the new Daly facility empowers TransCanna to increase its scope of offerings and establish its dominance in the California cannabis supply chain.

The Daly facility will anchor other TransCanna operations and serve as a supply chain hub for third party farms across Northern California, offering secure storage, concentrate manufacturing, wholesale market-making, white label services, and State-wide distribution.

Prior to achieving its cultivation license, the facility gained its distribution license in June 2020. Next, TransCanna is eagerly anticipating its processing license (pending approval by the State of California mid to late March) which will qualify the company to dry, cure, trim, grade, and package cannabis onsite. In addition to saving time and money for in-house brands with on-site processing, the processing license will enable TransCanna to open up new revenue streams servicing third party growers.

“California’s cannabis market is $5 billion in sales and growing, and we are well on our way to establishing ourselves at the epicenter of this category with our cultivation, processing, wholesaling and distribution arms of the entire California supply chain,” said Bob Blink, TransCanna CEO.

About TransCanna

TransCanna Holdings Inc. is a California-based, Canadian-listed company building cannabis-focused brands for the California lifestyle, through its wholly-owned California subsidiaries.

TransCanna’s wholly owned subsidiary Lyfted Farms is California’s authentic cannabis brand whose pioneering spirit has been continuously providing the finest cannabis flower genetics and cultivation methods since 1984. The Lyfted Farms brand of exclusive cannabis flower is sold at premium retailers throughout the state. With its new cultivation facility in Daly, California, the company is now poised to become one of the largest and most efficient vertically integrated cannabis companies in the California market.

Read more: https://agoracom.com/ir/TranscannaHoldings/forums/discussion/topics/755740-california-grants-cannabis-cultivation-license-to-transcanna/messages/2304595#message

TransCanna $TCAN.ca Final Stage of Phase One Completion at Daly Facility $VFF.ca $ACB.ca $GTII.ca $TEQ.ca

Posted by AGORACOM-JC at 8:12 AM on Wednesday, February 17th, 2021
tcan-square
  • Phase One expected to generate up to CAD$ 28,000,000 to $32,000,000 additional annual Revenues
  • Company anticipates the remaining construction to take 60 days from the date of execution of the Definitive Agreements with Wild Horse Properties L.P., which will provide the company access to a $2,000,000 convertible construction loan.

Vancouver, British Columbia — (February 17, 2021) – TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company“) is extremely excited to announce the Company has entered into the final stage of the Phase One build-out of its Daly Facility located in Modesto, CA. With the facility construction approximately 80% complete, the Company anticipates the remaining construction to take 60 days from the date of execution of the Definitive Agreements with Wild Horse Properties L.P., which will provide the company access to a $2,000,000 convertible construction loan.

“The entire team is thrilled to complete the remainder of the Phase One Daly Facility build-out. The opportunity ahead of us to scale our genetic offerings, cultivation, state-wide distribution and processing divisions is very exciting. Each of these functions have synergistic impacts on the efficiencies of the business. Top-tier manufacturing for concentrates will soon follow, significantly leveraging up the entire portfolio,” stated Alan Applonie, General Manager of the Daly Facility.

Once construction is complete, on or around April 15, 2021, the company will boast the following cultivation, distribution, and processing capabilities at its flagship Daly Facility:

Cultivation

  • Five (5) 4,500 sq. ft. grow rooms
  • Each new cultivation room is expected to add an additional $12-$14M CAD
  • The incremental gain of 500 lights represents a 330% increase over current capacity
  • Each room will be outfitted with a minimum of 100 lights.
  • The first completed cultivation room planned to have plants under lights by March 15, 2021

Distribution

  • Robust distribution infrastructure with secured loading and unloading of vans
  • Climate controlled storage facilities that can accommodate 100 acres of harvested product, cured bulk product, and more than 100 pallet positions for finished goods
  • Aggregation of the company’s crop management products
  • Finished goods from multiple brands and partners for efficient logistics between the Northern and Southern California markets
  • Revenue is expected to commence in March and to achieve an annualized run rate of $8-10M CAD

Processing

  • Curing, grading, and packaging of cannabis flower from compliant 3rd party farms
  • Provides the operational basis to execute a comprehensive white-label/co-packaging and brand creation center to fill lower price point market segments
  • Revenue is expected to begin in March and to achieve an annualized run rate of $8-10M CAD
  • State Processing License expected by March 15th, 2021

Read More: https://agoracom.com/ir/TranscannaHoldings/forums/discussion/topics/755487-final-stage-of-phase-one-completion-at-daly-facility/messages/2303991#message

TransCanna TCAN.ca Announces Binding Term Sheet for US$2 Million Secured Convertible Loan $VFF.ca $ACB.ca $CGC.ca $GTII.ca $TEQ.ca

Posted by AGORACOM-JC at 2:10 PM on Wednesday, February 3rd, 2021
tcan-square
  • Proceeds of the Convertible Loan are to be used exclusively for capital expenditures at the Company’s Daly Facility located in Modesto, California
  • Loan to Increase Production Capacity by 400% & Shift Company into a Cashflow Positive Status Once Daly Facility Opened

Vancouver, British Columbia–(February 3, 2021) – TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company“) is pleased to announce that it has entered into a binding term sheet (the “Term Sheet“) with Wild Horse Properties L.P. (the “Lender” or “Wild Horse“) for a secured convertible loan (the “Convertible Loan“) in the aggregate principal amount of US$2 million (the “Principal Amount.“).

The proceeds of the Convertible Loan are to be used exclusively for capital expenditures at the Company’s Daly Facility located in Modesto, California (the “Facility.“).

“We are excited to finally unlock the production capacity of the Daly Facility with this direct investment. We believe that scaling our cultivation capacity precipitates industrial level distribution, manufacturing and processing rewarding shareholders with significant revenue growth. We have been in the planning stage for several months,” stated Alan Applonie, Company General Manager, “and are very happy to have secured the necessary funding required to realize this vision.” A reminder to shareholders, Mr. Applonie comes from Taylor Farms an organic produce grower in the central valley where Alan was part of the original founding management team and responsible for annual gross revenues exceeding US$1 Billion.

The Facility build out consists of four phases; with receipt of the Company’s occupancy permit for Phase One, the Company will be shifting its distribution business from the Jerusalem property. Cultivation will continue at full capacity at the Jerusalem facility.

Read More: https://agoracom.com/ir/TranscannaHoldings/forums/discussion/topics/754587-transcanna-announces-binding-term-sheet-for-us-2-million-secured-convertible-loan/messages/2301895#message

VIDEO – Hollister $HOLL.ca $HSTRF Reported Record Q4 Revenues of CAD $14.93M From 370 Dispensaries In California and Arizona $CRON $GTBIF $INDS $META.ca $FAF.ca $WEED.ca

Posted by AGORACOM-JC at 7:42 PM on Sunday, January 31st, 2021
https://prnewswire2-a.akamaihd.net/p/1893751/sp/189375100/thumbnail/entry_id/1_dd2snc3b/def_height/400/def_width/400/version/100011/type/1

Hollister Biosciences (HOLL:CSE) is a multi-state operator with multiple, high-quality products that are now carried in over 280 dispensaries throughout California and over 90 dispensaries throughout Arizona.

Q4 Highlights:

  • Record quarterly revenue of CDN$14.93 million and CDN$2.53 million in EBITDA

Venom Extracts is their 100% owned subsidiary that is absolutely dominating the state of Arizona.  More than just lip service:

  • Since the closing (Venom), in the three quarters following, Venom contributed approximately CDN$38 million to the company’s 2020 revenue. 
  • In the entire year of 2020,
    • Venom generated greater than CDN$ 40 million in revenue (and CDN$ 4.9 million in adjusted EBITDA),
    • Up from CDN$ 16.4 million in 2019 a 144% year over year revenue increase, and ending the year with a record month of sales for December totaling approximately CDN$5.5 million .
  • Sold over 4 million grams of product in 2020
    • accounting for up to 30 percent of category sales statewide in Arizona .
  • Positioned for continued growth in Arizona with the recently passed adult-use legislation
  • Marijuana Business Daily projects that Arizona’s recreational market could generate up to $400 million in revenue its first year and more than $700 million by 2024.
  • ….. And it is run by the absolute coolest guy in small cap Cannabis – Jake Cohen  

Watch this interview or listen by Podcast on AppleGoogleSpotify or your favourite podcaster.

Hollister Biosciences Inc. $HOLL.ca $HSTRF Commends the State of Arizona for starting Adult-Use Cannabis Sales ahead of schedule, Venom Extracts it’s 100% owned subsidiary is a category leader with over 4 million grams sold throughout the state in 2020 $CRON $GTBIF $INDS $META.ca $FAF.ca $WEED.ca

Posted by AGORACOM-JC at 8:21 AM on Monday, January 25th, 2021
https://prnewswire2-a.akamaihd.net/p/1893751/sp/189375100/thumbnail/entry_id/1_dd2snc3b/def_height/400/def_width/400/version/100011/type/1
  • Branded Products now on sale in over 370 cannabis dispensaries in Arizona and California
  • 4 owned brands, and 3 brand collaborations
  • Over 4 million grams sold
  • Over 96,000 lbs. of cannabis biomass converted into finished products in Arizona
  • Total sales for 2020 increased 3233% from 2019 and are estimated to be approximately CDN $40 million
  • December 2020 sales totaled greater than CDN$6 million

VANCOUVER, BC , Jan. 25, 2021 – Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF) (FRANKFURT: HOB) (the ” Company “, “Hollister Cannabis Co .” or ” Hollister “) a diversified cannabis branding company with products in over 98 dispensaries throughout Arizona , is pleased to commend the state of Arizona for its efficient activation of adult-use cannabis sales. Legal sales of adult use cannabis in Arizona commenced mid-day on Friday January 22 nd , 2021, several months ahead of industry expectations, and the fastest that any of the 15 states with recreational marijuana has gone from voter approval to actual sales.

The company’s wholly owned subsidiary, Venom Extracts (” Venom “) product suite is a category leader with over 4 million grams sold in 2020, accounting for up to 30 percent of category sales state-wide. Venom is positioned for continued growth in Arizona , it has a strong brand recognition and distribution network, its products are available at leading retailers including Harvest Health and Recreation (CSE: HARV , OTCQX: HRVSF ), Curaleaf (CSE: CURA , OTCQX: CURLF ), Bloom, MuV and Oasis Cannabis dispensaries among others.

Arizona voted to legalize adult use cannabis in November, “Marijuana Business Daily projects that the state’s recreational market could generate up to $400 million in revenue its first year and more than $700 million by 2024”.

Read More: https://agoracom.com/ir/HollisterBiosciences/forums/discussion/topics/753842-hollister-biosciences-inc-commends-the-state-of-arizona-for-starting-adult-use-cannabis-sales-ahead-of-schedule-venom-extracts-it-s-100-owned/messages/2300014#message

Hollister Biosciences Inc. $HOLL.ca $HSTRF Announces an Increase in Private Placement to $6.5 Million $CRON $GTBIF $INDS $META.ca $FAF.ca $WEED.ca

Posted by AGORACOM-JC at 12:46 PM on Thursday, January 21st, 2021
https://prnewswire2-a.akamaihd.net/p/1893751/sp/189375100/thumbnail/entry_id/1_dd2snc3b/def_height/400/def_width/400/version/100011/type/1

  • Announced that it has entered into an amended letter of engagement with Eight Capital, pursuant to which Eight Capital, acting as sole bookrunner and lead agent, has now agreed to offer for sale, together with a syndicate of agents 17,810,000 Special Warrants of the Company on a “best efforts” private placement basis, subject to all required regulatory approvals, at a price per Special Warrant of $0.365 for total gross proceeds of up to $6,500,650
  • Each Special Warrant shall be automatically exercisable into units of the Company, as described below. Each Unit shall consist of one common share of the Company and one-half of one common share purchase warrant

VANCOUVER, British Columbia, Jan. 21, 2021 — Hollister Biosciences Inc. (CSE:HOLL, OTC:HSTRF, FRANKFURT:HOB) (“ Hollister ” or the “ Company ”) is pleased to announce that it has entered into an amended letter of engagement with Eight Capital, pursuant to which Eight Capital, acting as sole bookrunner and lead agent, has now agreed to offer for sale, together with a syndicate of agents (together with Eight Capital, the “ Agents ”), 17,810,000 Special Warrants of the Company (the “ Special Warrants ”), on a “best efforts” private placement basis, subject to all required regulatory approvals, at a price per Special Warrant of $0.365 (the “ Issue Price ”) for total gross proceeds of up to $6,500,650 (the “ Offering ”).

Each Special Warrant shall be automatically exercisable into units of the Company (the “ Units ”), as described below. Each Unit shall consist of one common share of the Company (a “ Share ”) and one-half of one common share purchase warrant (each full warrant, a “ Warrant ”). Each Warrant shall entitle the holder thereof to acquire one Share at a price of $0.50 per Share for a period of 46 months following the Closing Date.

Each Special Warrant shall be automatically exercisable, for no additional consideration, into Units on the date (the “ Automatic Exercise Date ”) that is the earlier of: (i) the date that is three business days following the date on which the Company either (A) obtains a receipt from the applicable securities regulatory authorities (the “ Securities Commissions ”) for a (final) short form prospectus qualifying distribution of the Units underlying the Special Warrants (the “ Qualifying Prospectus ”); or (B) files a supplement to a (final) short form base shelf prospectus qualifying the distribution of the Units underlying the Special Warrants (the “ Qualifying Supplement ”), and (ii) the date that is four months and one day after the Closing of the Offering.

Read More: https://agoracom.com/ir/HollisterBiosciences/forums/discussion/topics/753581-hollister-biosciences-inc-announces-an-increase-in-private-placement-to-6-5-million/messages/2299280#message

Hollister Biosciences Inc. $HOLL.ca $HSTRF Provides Update on Q4 2020 Performance Including CDN $14.93 Million in Revenue With an Estimated CDN $2.53 Million in EBITDA a YoY Revenue Increase of 3215% from Q4 2019 $CRON $GTBIF $INDS $META.ca $FAF.ca $WEED.ca

Posted by AGORACOM-JC at 7:44 AM on Friday, January 8th, 2021
https://prnewswire2-a.akamaihd.net/p/1893751/sp/189375100/thumbnail/entry_id/1_dd2snc3b/def_height/400/def_width/400/version/100011/type/1
  • For the period beginning October 1 st , 2020 and ending December 31 st , 2020, Hollister reports that it generated record quarterly revenue of CDN$14.93 million and CDN$2.53 million in EBITDA from its product line of pre-rolls, concentrates, distillates, solvent-free bubble hash, pre-packaged flower, tinctures and vape products.
  • “We are very pleased with our ability to deliver record quarterly revenue in such a challenging market environment. We attribute our revenue growth to further penetration of the California and Arizona dispensary networks and successful new product launches with our joint venture partners. Sales of cannabis related products continue to show resilience throughout the COVID-19 pandemic. We hope to continue this positive momentum into 2021” stated Alex Somjen , President.

VANCOUVER, BC , Jan. 7, 2021 – Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF) (FRANKFURT: HOB) (the ” Company “, ” Hollister Cannabis Co .” or ” Hollister “) a diversified cannabis branding company with products in over 280 dispensaries throughout California , and over 90 dispensaries throughout Arizona , is pleased to provide an update on its Q4, 2020 performance.

Q4 2020 Update

For the period beginning October 1 st , 2020 and ending December 31 st , 2020, Hollister reports that it generated record quarterly revenue of CDN$14.93 million and CDN$2.53 million in EBITDA from its product line of pre-rolls, concentrates, distillates, solvent-free bubble hash, pre-packaged flower, tinctures and vape products. The Company cautions that revenue and EBITDA figures have not yet been audited and are based on reports prepared by management.

“We are very pleased with our ability to deliver record quarterly revenue in such a challenging market environment. We attribute our revenue growth to further penetration of the California and Arizona dispensary networks and successful new product launches with our joint venture partners. Sales of cannabis related products continue to show resilience throughout the COVID-19 pandemic. We hope to continue this positive momentum into 2021” stated Alex Somjen , President.

Read More: https://agoracom.com/ir/HollisterBiosciences/forums/discussion/topics/752594-hollister-biosciences-inc-provides-update-on-q4-2020-performance-including-cdn-14-93-million-in-revenue-with-an-estimated-cdn-5-53-million-in/messages/2296579#message

TransCanna $TCAN.ca Subsidiary Exceeds 30% THC In Independent Test $VFF.ca $ACB.ca $CGC.ca $GTII.ca $TEQ.ca

Posted by AGORACOM-JC at 7:35 AM on Thursday, January 7th, 2021
tcan-square
  • Announces record THC test results achieved via data driven process improvements at wholly owned subsidiary Lyfted Farms.
  • Recent testing by a State certified, third party laboratory confirmed total THC to be 31.3% and total cannabinoids at 41.43% for the Lyfted Farms’ Garlic NoodlesTM cannabis flower, both are record levels for Lyfted Farms indoor cultivation team.
  • Notably, total flower yield also increased by 17%.

Vancouver, British Columbia–(January 7, 2021) – TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) announces record THC test results achieved via data driven process improvements at wholly owned subsidiary Lyfted Farms.

Recent testing by a State certified, third party laboratory confirmed total THC to be 31.3% and total cannabinoids at 41.43% for the Lyfted Farms’ Garlic NoodlesTM cannabis flower, both are record levels for Lyfted Farms indoor cultivation team. Notably, total flower yield also increased by 17%.

Systematic, data driven process enhancements to multiple facets of the genetics-to-harvest cycle have resulted in superior test results for total THC, total cannabinoids, and yield metrics.

Read More: https://agoracom.com/ir/TranscannaHoldings/forums/discussion/topics/752519-transcanna-subsidiary-exceeds-30-thc-in-independent-test/messages/2296437#message